Published in J Neurosurg on February 01, 2006
Cerebellar mutism: review of the literature. Childs Nerv Syst (2011) 2.22
Cerebellocerebral diaschisis is the likely mechanism of postsurgical posterior fossa syndrome in pediatric patients with midline cerebellar tumors. AJNR Am J Neuroradiol (2009) 1.64
Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome. Childs Nerv Syst (2013) 1.61
Proximal dentatothalamocortical tract involvement in posterior fossa syndrome. Brain (2009) 1.03
Postoperative posterior fossa syndrome: unraveling the etiology and underlying pathophysiology by using magnetic resonance imaging. Childs Nerv Syst (2015) 0.94
Diffusion abnormalities on intraoperative magnetic resonance imaging as an early predictor for the risk of posterior fossa syndrome. Neuro Oncol (2014) 0.90
MR imaging evaluation of inferior olivary nuclei: comparison of postoperative subjects with and without posterior fossa syndrome. AJNR Am J Neuroradiol (2013) 0.88
Cerebellar mutism. Childs Nerv Syst (2015) 0.86
Postoperative cerebellar mutism in adult patients with Lhermitte-Duclos disease. Neurosurg Rev (2010) 0.83
Cerebellar Mutism Syndrome After Posterior Fossa Surgery: A Report of Two Cases of Pilocytic Astrocytoma. Noro Psikiyatr Ars (2013) 0.75
Posterior fossa syndrome with delayed MR evidence of unilateral superior cerebellar peduncle (SCP) damage. Childs Nerv Syst (2016) 0.75
Post-operative diffusion weighted imaging as a predictor of posterior fossa syndrome permanence in paediatric medulloblastoma. Childs Nerv Syst (2017) 0.75
Description and first clinical application of AirWay Scope for tracheal intubation. J Neurosurg Anesthesiol (2006) 2.63
Radiometric analysis of paraclinoid carotid artery aneurysms. J Neurosurg (2002) 2.12
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res (2010) 2.07
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer (2010) 1.70
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res (2006) 1.65
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res (2008) 1.58
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res (2011) 1.57
Role of endothelial nitric oxide and smooth muscle potassium channels in cerebral arteriolar dilation in response to acidosis. Stroke (2002) 1.53
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis (2011) 1.51
Emergency embolectomy for treatment of acute middle cerebral artery occlusion. J Neurosurg (2007) 1.47
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res (2012) 1.46
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer (2008) 1.45
Spinal intradural extramedullary cavernous angioma presenting with superficial siderosis and hydrocephalus: a case report and review of the literature. Intern Med (2014) 1.45
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis (2009) 1.44
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res (2006) 1.41
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One (2012) 1.35
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One (2013) 1.27
Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One (2012) 1.26
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res (2007) 1.25
Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst (2002) 1.24
MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One (2013) 1.23
Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer (2010) 1.23
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) (2010) 1.22
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21
Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem (2014) 1.21
Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One (2013) 1.19
Characteristics of distal posteroinferior cerebellar artery aneurysms. Neurosurgery (2003) 1.19
Natural course of myopic traction maculopathy and factors associated with progression or resolution. Am J Ophthalmol (2013) 1.18
Three-dimensional microsurgical and tractographic anatomy of the white matter of the human brain. Neurosurgery (2008) 1.16
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One (2013) 1.16
miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res (2012) 1.16
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res (2005) 1.14
Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer (2006) 1.11
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One (2012) 1.11
CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res (2007) 1.11
Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta (2006) 1.10
Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One (2012) 1.09
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res (2010) 1.08
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis (2011) 1.06
Mechanism of ATP-induced local and conducted vasomotor responses in isolated rat cerebral penetrating arterioles. J Vasc Res (2008) 1.05
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One (2012) 1.05
The claustrum and its projection system in the human brain: a microsurgical and tractographic anatomical study. J Neurosurg (2008) 1.05
Ruptured distal middle cerebral artery aneurysm. J Neurosurg (2004) 1.05
DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer (2008) 1.03
Double-insurance bypass for internal carotid artery aneurysm surgery. Neurosurgery (2003) 1.03
Mechanism of extracellular K+-induced local and conducted responses in cerebral penetrating arterioles. Stroke (2002) 1.02
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res (2007) 1.01
Safe and minimally invasive laminoplastic laminotomy using an ultrasonic bone curette for spinal surgery: technical note. Surg Neurol (2009) 1.01
Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res (2009) 1.01
Standard and limitation of intraoperative monitoring of the visual evoked potential. Acta Neurochir (Wien) (2010) 1.01
Emergency EC-IC bypass for symptomatic atherosclerotic ischemic stroke. Neurosurg Rev (2013) 1.01
Posterior auricular artery-middle cerebral artery bypass for additional surgery of moyamoya disease. Acta Neurochir (Wien) (2011) 1.00
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer (2005) 1.00
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res (2012) 1.00
Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol (2005) 0.99
NeuRobot: telecontrolled micromanipulator system for minimally invasive microneurosurgery-preliminary results. Neurosurgery (2002) 0.99
Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats. J Urol (2003) 0.97
Clip blade scissoring with titanium bayonet clip in aneurysm surgery. Two case reports. Neurol Med Chir (Tokyo) (2012) 0.97
Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol (2008) 0.97
Globular subdural hematoma in a shunt-treated infant: case report. J Neurosurg Pediatr (2010) 0.96
Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer (2011) 0.96
Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles. Stroke (2003) 0.96
The concept and feasibility of EXPERT: intelligent armrest using robotics technology. Neurosurgery (2013) 0.95
Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg (2003) 0.95
Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun (2006) 0.95
Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Clin Cancer Res (2004) 0.94
Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Mol Cell Endocrinol (2003) 0.94
Subtle computed tomography abnormalities in cerebral deep sinus thrombosis. J Clin Neurosci (2006) 0.94
Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun (2004) 0.92
A case report and review of the literature. J Neurooncol (2006) 0.92
Surgical treatment for aneurysmal subarachnoid hemorrhage in the 8th and 9th decades of life. Neurosurgery (2005) 0.91
CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res (2003) 0.91
Emergency revascularization for acute main-trunk occlusion in the anterior circulation. Neurosurg Rev (2007) 0.91
Suboccipital approach for primitive trigeminal artery obliteration associated with cavernous aneurysm. World Neurosurg (2011) 0.91
Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int J Oncol (2003) 0.91
Parkinsonism and midbrain dysfunction after shunt placement for obstructive hydrocephalus. J Clin Neurosci (2006) 0.90
Multiple-locus variable-number of tandem-repeats analysis distinguishes Vibrio parahaemolyticus pandemic O3:K6 strains. J Microbiol Methods (2008) 0.90
Clinical application of robotic telemanipulation system in neurosurgery. Case report. J Neurosurg (2003) 0.89
Operation-microscope-mounted touch display tablet computer for intraoperative imaging visualization. World Neurosurg (2011) 0.89